Single dose of powerful psychedelic cuts depression symptoms in clinical study

A single dose of psychedelics significantly reduced symptoms in people with major depressive disorder, a new study found.

The clinical trial was led by researchers at Imperial College London, where the team found that participants with depression who took the psychedelic dimethyltryptamine (DMT) had greater reductions in the severity of their condition compared to those who took a placebo.

DMT is a naturally occurring psychedelic, similar to compounds found in "magic mushrooms" and serotonin...